Literature DB >> 6154429

Residual, inoperable or recurrent colorectal cancer. Interaction of surgery and radiotherapy.

L L Gunderson, A M Cohen, C E Welch.   

Abstract

For irradiation of inoperable, residual or recurrent colorectal cancers, doses of 4,500 to 5,000 rads can achieve short-term palliation; doses must be increased to 6,000 to 7,000 rads or more, however, if long-term control of disease or possible cure is desired. The ability to achieve those dose levels safely depends on close interaction between the surgeon, the radiation oncologist and the diagnostic radiologist in defining and displacing normal and tumor tissues. Methods used at Massachusetts General Hospital from March 1976 to August 1979 are defined. They include the use of operative clips and pelvic reconstruction, diagnostic computed tomography and ultrasound, radiotherapy optimization including shrinking field techniques, radiation with bladder distention and single intraoperative boost doses given in combination with external beam.

Entities:  

Mesh:

Year:  1980        PMID: 6154429     DOI: 10.1016/0002-9610(80)90330-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Palliative treatment of rectal cancer: is radiotherapy alone a good option?

Authors:  Christopher G Willett; Leonard L Gunderson
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

2.  Intraoperative and external beam irradiation for locally advanced colorectal cancer.

Authors:  L L Gunderson; J K Martin; R W Bèart; D M Nagorney; J M Fieck; H S Wieand; A Martinez; M J O'Connell; J A Martenson; D C McIlrath
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

3.  Radiation therapy of rectal cancer.

Authors:  A M Cohen; L L Gunderson; C E Welch
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

4.  Dose Escalation with Simultaneous Integrated Boost (SIB) Using Volumetric Modulated Arc Therapy (VMAT) in Rectal Cancer.

Authors:  Abdullah Alsuhaibani; Ahmed Elashwah; Rana Mahmood; Alaa Abduljabbar; Samar Alhomoud; Luai Ashari; Shouki Bazarbashi; Ali Aljubran; Ahmed Alzahrani; Muhamed Mohiuddin; Hadeel Almanea; Hussah Alhussaini; Nasser AlSanea
Journal:  J Gastrointest Cancer       Date:  2018-07-14

5.  Tolerance of retroperitoneal structures to intraoperative radiation.

Authors:  W F Sindelar; J Tepper; E L Travis; R Terrill
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

6.  Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer.

Authors:  Sun Hyun Bae; Won Park; Doo Ho Choi; Heerim Nam; Won Ki Kang; Young Suk Park; Joon Oh Park; Ho Kyung Chun; Woo Yong Lee; Seong Hyeon Yun; Hee Cheol Kim
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.